Conference
A phase I/Il Study of erlotinib (Tarceva) in combination with cisplatin in patients with recurrent or metastatic squamous cell cancer of the head and neck (HNSCC).
Authors
Siu LL; Chen X; Tsao M; Dancey J; Pond GR; Klein M; Winquist E
Volume
9
Pagination
pp. 6091S-6091S
Publisher
AMER ASSOC CANCER RESEARCH
Publication Date
December 1, 2003
Name of conference
AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Conference place
BOSTON, MASSACHUSETTS
Conference start date
November 17, 2003
Conference end date
November 21, 2003
Conference proceedings
CLINICAL CANCER RESEARCH
Issue
16
ISSN
1078-0432